Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A tumor-associated beta 1 integrin mutation that abrogates epithelial differentiation control.

Richard D Evans1, Vivienne C Perkins, Alistair Henry

  • 1Keratinocyte Laboratory, Cancer Research UK London Research Institute, London WC2A 3PX, UK.

The Journal of Cell Biology
|February 13, 2003
PubMed
Summary

A novel mutation in beta 1 integrin (T188I) constitutively activates ligand binding in SCC4 cells, hindering keratinocyte differentiation. This finding reveals how integrin mutations can drive cancer development and progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dermal papillary fibroblasts promote persistent granulation tissue formation in junctional epidermolysis bullosa.

EMBO molecular medicine·2026
Same author

Severe and widespread coral reef damage during the 2014-2017 Global Coral Bleaching Event.

Nature communications·2026
Same author

At the helm of JCS - Editors-in-Chief past, present… and future.

Journal of cell science·2025
Same author

Cell volume regulates terminal differentiation of cultured human epidermal keratinocytes.

Journal of cell science·2025
Same author

Controlled anarchy.

EMBO reports·2025
Same author

Fetal Fibroblast Heterogeneity Defines Dermal Architecture during Human Embryonic Skin Development.

The Journal of investigative dermatology·2025

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • SCC4 human keratinocytes, derived from tongue squamous cell carcinoma, exhibit minimal spontaneous differentiation.
  • Introduction of wild-type beta 1 integrin subunit into SCC4 cells promotes differentiation, suggesting potential defects in integrin signaling or the beta 1 subunit itself.

Purpose of the Study:

  • To identify and characterize mutations in the beta 1 integrin subunit of SCC4 cells.
  • To investigate the functional consequences of a specific beta 1 integrin mutation on keratinocyte differentiation and cancer development.

Main Methods:

  • Heterozygous mutation analysis of the beta 1 integrin subunit in SCC4 cells.
  • Functional assays using recombinant proteins and living cells to assess ligand binding and cell behavior.

Related Experiment Videos

  • Introduction of wild-type and mutant beta 1 integrin into SCC4 keratinocytes and normal keratinocytes.

    • Main Results:

    • A heterozygous mutation, T188I, was identified in the SCC4 beta 1 integrin subunit, located in the I-like domain.
    • The T188I mutation leads to constitutive activation of ligand binding, independent of the alpha subunit, promoting cell spreading but not proliferation, motility, or invasiveness.
    • Sustained activation of Erk MAPK was observed, independent of cell spreading.
    • Wild-type beta 1 integrin stimulated differentiation in SCC4 cells, while the mutant form was inactive. Conversely, activating beta 1 integrins in normal keratinocytes suppressed differentiation.

    Conclusions:

    • Mutation is established as a mechanism by which integrins can contribute to neoplasia, as impaired epithelial cancer differentiation correlates inversely with prognosis.
    • The study provides novel insights into the regulation of keratinocyte differentiation by integrins and the role of integrin mutations in cancer.